fda green list glp-1 import alert 66-80 GLP-1, List, Compounded weight-loss and hormone drugs

Segment Insights Study Type Insights The pivotal study segment stood dominant by generating the highest share in 2025

Sources: Khavinson VK, et al

These medications are FDA-approved for chronic weight management in adults with a BMI of 30 or greater (obesity) or a BMI of 27 or greater (overweight) with at least one weight-related health condition such as hypertension, type 2 diabetes, or high cholesterol

Kan Cao , Human Aging Scientist, Professor of Cell Biology and Molecular Genetics at University of Maryland College Park, and Chief Science Officer at Mblue Labs, identifies the underlying causes of skin deflation from medical weight loss